CRCI2NA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers

Type: Research entity evaluation report

Evaluation campaign: 2020-2022 (group B) - Published on: 29/09/2021

Institution(s) concerned: Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM , Université d'Angers , Université de Nantes

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE5 Physiology, Physiopathology, Cardiology, Pharmacology, Enocrinology, Cancer, Medical Technologies

Scientific field(s): 5 - Biologie, medecine et santé

ERC panel(s): LS6 Immunity and infection: immunobiology, aetiology of immune disorders, microbiology, virology, parasitology, global and other infectious diseases, population dynamics of infectious diseases, veterinary medicine

Name of unit teams: Immunomodulation of the tumor microenvironment and Immunotherapy of thoracic cancers ; Nuclear Oncology ; Senescence Escape and soluble markers of cancer progression ; Innate Immunity and Cancer ; Design and Application of Innovative Loco-regional Treatments in Glioblastoma ; Signaling in Oncogenesis, Angiogenesis and Permeability ; Stress Adaptation and Tumor Escape ; Integrative cancer genomics ; Chromatin and transcrIptionaL Deregulation in pediatric bone sarcoma ; Plasticity of the Ecosystem of the tumor after RadiotherapY ; Molecular vulnerabilities of tumor escape in B-cell malignancies ; Manipulation of lymphocytes for immunotherapy